Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
ADVANCED MARKER DISCOVERY S.L.
With
European Union
Age
50–75
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Participants between the ages of 50 and 75 (both included) at the time of informed consent signed. They must understand the nature, significance, implications and risks of the clinical trial and must sign the informed consent form.
Participants referred to the gastroenterology service who are going to undertake colonoscopy as a regular procedure for screening setting.
Participants asymptomatic, average risk for CRC. Average risk is defined as those individuals who are age 50 or older with no history of adenoma, colorectal cancer, or inflammatory bowel disease, and with no family history of CRC (first degree relatives).
You may not be if
Participants between the ages of 50 and 75 (both included) at the time of Informed consent signature. They must understand the nature, significance, implications and risks of the clinical trial and must sign the informed consent form.
Participants who have been diagnosed with CRC. The diagnosis must be subsequently confirmed by biopsy or surgery and pathological anatomy analysis during the study.
Clareo Health | Validation of a Molecular Signature for Early Detection of Colorectal Cancer
